Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Boxer

Showing results (221-230 of 300) with videos related to

Pageof 30
Sort By:
Nature Medicine|March 4, 2020
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degenerationElisabeth H Thijssen, Renaud La Joie, Amy Wolf, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Neurology|May 18, 2022
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal DementiaGianina Toller, Yann Cobigo, Peter A Ljubenkov, et al.
Neurobiology of Aging|December 13, 2023
Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortiumNick Corriveau-Lecavalier, Nirubol Tosakulwong, Timothy G Lesnick, et al.
Neurology|July 3, 2024
CSF Proteomics in Patients With Progressive Supranuclear PalsyAmy Wise, Jingyao Li, Mai Yamakawa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresAdam L Boxer, Michael Gold, Howard Feldman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
At the interface of sensory and motor dysfunctions and Alzheimer's diseaseMark W Albers, Grover C Gilmore, Jeffrey Kaye, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Journal of the International Neuropsychological Society : JINS|October 30, 2025
Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trialsMark Sanderson-Cimino, Katherine L Possin, Dan M Mungas, et al.
JAMA Neurology|June 22, 2026
Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal DementiaMolly Olzinski, Joshua Downer, Yann Cobigo, et al.
Pageof 30

Showing results (221-230 of 300) with videos related to

Sort By:
Pageof 30
Nature Medicine|March 4, 2020
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degenerationElisabeth H Thijssen, Renaud La Joie, Amy Wolf, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Neurology|May 18, 2022
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal DementiaGianina Toller, Yann Cobigo, Peter A Ljubenkov, et al.
Neurobiology of Aging|December 13, 2023
Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortiumNick Corriveau-Lecavalier, Nirubol Tosakulwong, Timothy G Lesnick, et al.
Neurology|July 3, 2024
CSF Proteomics in Patients With Progressive Supranuclear PalsyAmy Wise, Jingyao Li, Mai Yamakawa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresAdam L Boxer, Michael Gold, Howard Feldman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
At the interface of sensory and motor dysfunctions and Alzheimer's diseaseMark W Albers, Grover C Gilmore, Jeffrey Kaye, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Journal of the International Neuropsychological Society : JINS|October 30, 2025
Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trialsMark Sanderson-Cimino, Katherine L Possin, Dan M Mungas, et al.
JAMA Neurology|June 22, 2026
Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal DementiaMolly Olzinski, Joshua Downer, Yann Cobigo, et al.
Pageof 30